[1] Li X, Li C, Zhang L, et al. The significance of exosomes in the development and treatment of hepatocellular carcinoma[J]. Mol Cancer, 2020,19:1-11. [2] Ogunwobi OO, Harricharran T, Huaman J, et al. Mechanisms of hepatocellular carcinoma progression[J]. World J Gastroenterol, 2019,25:2279-2293. [3] Liu J, Zong G, Zhang C, et al. Anxiety and serum catecholamines as predictors of survival and recurrence in hepatocellular carcinoma[J]. Psychooncology, 2017,26:1347-1353. [4] Kreso A, Dick JE. Evolution of the cancer stem cell model[J]. Cell Stem Cell, 2014,14:275-291. [5] Takeishi S, Nakayama KI. To wake up cancer stem cells, or to let them sleep, that is the question[J]. Cancer Sci, 2016,107:875-881. [6] Kim KH, Sederstrom JM. Assaying cell cycle status using flow cytometry[J]. Curr Protoc Mol Biol, 2015,111:601-617. [7] Huang W, Yuan X, Sun T, et al. Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells[J]. Front Pharmacol, 2017,8:1-10. [8] Wang R, Sun Q, Wang P, et al. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells[J]. Oncotarget, 2016,7:5754-5768. [9] 吕艳, 牛昀, 丁秀敏, 等. Skp2和p27kip1表达异常与 乳腺癌发生及临床病理特征的相关性研究[J]. 诊断病理学杂志, 2015,22:429-432. [10] Bencivenga D, Caldarelli I, Stampone E, et al. p27kip1 and human cancers: A reappraisal of a still enigmatic protein[J]. Cancer Lett, 2017,403:354-365. |